REPORT: Diabetes in Jakarta–Rx Market SnapShot 2016

With one of the largest diabetic patient populations in Asia and millions of undiagnosed cases, Indonesia poses both opportunities and challenges for healthcare organizations focused on diabetes. For those seeking insight on this topic, mClinica is pleased to present its first SnapShot report on Jakarta, Indonesia’s most important healthcare hub. Using mClinica’s proprietary prescription datasets, the … Continue reading REPORT: Diabetes in Jakarta–Rx Market SnapShot 2016

REPORT: Antibiotics in Jakarta–Rx Market SnapShot 2016

Antibiotics are one of the most widely prescribed types of medicines in Indonesia today, but data on their usage is not widely available. For healthcare organizations seeking insight on the current state of Indonesia’s antibiotics market, mClinica is pleased to present its first SnapShot report on the OOP market in Jakarta, Indonesia’s most important healthcare … Continue reading REPORT: Antibiotics in Jakarta–Rx Market SnapShot 2016

REPORT: Diabetes in Ho Chi Minh City–Rx Market SnapShot 2016

Vietnam has one of the fastest-growing diabetic patient populations in Asia. As incidence soars, pharmaceutical companies and healthcare providers are racing to keep up with demand for diabetes treatments. Epidemiological and regulatory shifts further complicate the picture, making careful monitoring of market dynamics a necessity. For healthcare organizations seeking insight on the current state of … Continue reading REPORT: Diabetes in Ho Chi Minh City–Rx Market SnapShot 2016

How mClinica Can Support AMR Surveillance in Southeast Asia

As global health organizations ramp up efforts to fight the spread of drug-resistant microbes, many recognize a growing need to collect robust data on risk factors for antimicrobial resistance (AMR). At mClinica, we have data collection and patient engagement platforms that can help. We manage these platforms in Asia’s emerging markets. In the Philippines, Indonesia, … Continue reading How mClinica Can Support AMR Surveillance in Southeast Asia

REPORT: Antibiotics in Ho Chi Minh City—Rx Market SnapShot 2016

Antibiotics are one of the most widely prescribed types of medicines in Vietnam today, but market dynamics for these critical medicines are not widely understood. For healthcare organizations seeking insight on the current state of Vietnam’s antibiotics market, mClinica is pleased to present its first SnapShot report on the OOP market in Ho Chi Minh … Continue reading REPORT: Antibiotics in Ho Chi Minh City—Rx Market SnapShot 2016

mClinica Wins USAID Award for Data-Driven Innovation

Above: mClinica Chief Digital Officer Will Greene receives the Data for Resilience Award at USAID’s regional headquarters in Bangkok. On May 11, we had the privilege of presenting at the Data for Resilience Summit, a conference on data-driven strategies for promoting sustainable development. The conference, which was hosted by USAID Asia and FHI360, included a … Continue reading mClinica Wins USAID Award for Data-Driven Innovation

Diabetes in Ho Chi Minh City: Rx Trends Reveal Market Shifts

To address Vietnam’s growing diabetes epidemic, healthcare organizations must improve access to high-quality treatments. Efforts are needed throughout the country, but Ho Chi Minh City requires special attention. As Vietnam’s largest city, Ho Chi Minh City (HCMC) has more diabetics than anywhere else in the country. Incidence of the disease is significantly above the national … Continue reading Diabetes in Ho Chi Minh City: Rx Trends Reveal Market Shifts

Diabetes Threatens Vietnam’s Healthcare Systems

Diabetes is a major problem in Vietnam today. It afflicts millions of people in the country, and incidence of the disease is growing at alarming rates. Addressing this problem will require improved measures to prevent, diagnose, and treat the disease. Public and private healthcare organizations need to act fast before it’s too late. On the … Continue reading Diabetes Threatens Vietnam’s Healthcare Systems

Southeast Asia’s Growing Diabetes Epidemic

Diabetes afflicts more than 25 million Southeast Asians today. As incidence of the disease grows across the region, healthcare systems face mounting pressures. Yet interventions designed for developed countries will have little impact in emerging markets like Indonesia, the Philippines, and Vietnam. To address the problem in places like these, healthcare organizations need better sources … Continue reading Southeast Asia’s Growing Diabetes Epidemic

Reflections on the IBM Watson Asia-Pacific New Venture Challenge

Above: mClinica’s Software Team Lead Jake Josol (right) and CFO Jon Lin (center) with Tim Greisinger, Managing Director of IBM Singapore.  Last month, we had the pleasure and privilege of presenting at the IBM Watson Asia-Pacific New Venture Challenge in Singapore. Of the numerous applicants and 25 final contenders who took to the stage that day, … Continue reading Reflections on the IBM Watson Asia-Pacific New Venture Challenge